These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32335064)

  • 1. Inhibitors of blood coagulation factor XIII.
    Schmitz T; Bäuml CA; Imhof D
    Anal Biochem; 2020 Sep; 605():113708. PubMed ID: 32335064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
    Protopopova AD; Ramirez A; Klinov DV; Litvinov RI; Weisel JW
    J Thromb Haemost; 2019 May; 17(5):737-748. PubMed ID: 30773828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a).
    Pasternack R; Büchold C; Jähnig R; Pelzer C; Sommer M; Heil A; Florian P; Nowak G; Gerlach U; Hils M
    J Thromb Haemost; 2020 Jan; 18(1):191-200. PubMed ID: 31578814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII and venous thromboembolism.
    Bereczky Z; Muszbek L
    Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methods for the determination of factor XIII/XIIIa].
    Wilmer M; Schröder V; Kohler HP
    Hamostaseologie; 2002 Feb; 22(1):32-42. PubMed ID: 12193983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of coagulation factor XIII in cardio- and cerebrovascular diseases].
    Kohler HP; Schröder V
    Hamostaseologie; 2002 Feb; 22(1):53-8. PubMed ID: 12193986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin.
    Achyuthan KE; Rowland TC; Birckbichler PJ; Lee KN; Bishop PD; Achyuthan AM
    Mol Cell Biochem; 1996 Sep; 162(1):43-9. PubMed ID: 8905624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into structure and function of factor XIIIa-inhibitor tridegin.
    Böhm M; Bäuml CA; Hardes K; Steinmetzer T; Roeser D; Schaub Y; Than ME; Biswas A; Imhof D
    J Med Chem; 2014 Dec; 57(24):10355-65. PubMed ID: 25415134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D; Matsueda GR; Haber E; Reed GL
    Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the inhibition of coagulation factor XIII-A from animal species revealed by Michael Acceptor- and thioimidazol based blockers.
    Heil A; Weber J; Büchold C; Pasternack R; Hils M
    Thromb Res; 2013 May; 131(5):e214-22. PubMed ID: 23498170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.
    Al-Horani RA; Kar S
    Eur J Med Chem; 2020 Aug; 200():112442. PubMed ID: 32502864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
    Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS
    Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure functional insights into calcium binding during the activation of coagulation factor XIII A.
    Singh S; Dodt J; Volkers P; Hethershaw E; Philippou H; Ivaskevicius V; Imhof D; Oldenburg J; Biswas A
    Sci Rep; 2019 Aug; 9(1):11324. PubMed ID: 31383913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking.
    Souri M; Yokoyama C; Osaki T; Ichinose A
    Thromb Haemost; 2023 Sep; 123(9):841-854. PubMed ID: 36934722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
    Bagoly Z; Haramura G; Muszbek L
    Thromb Haemost; 2007 Aug; 98(2):359-67. PubMed ID: 17721618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
    Richardson VR; Cordell P; Standeven KF; Carter AM
    Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.
    Nikolajsen CL; Dyrlund TF; Poulsen ET; Enghild JJ; Scavenius C
    J Biol Chem; 2014 Mar; 289(10):6526-6534. PubMed ID: 24443567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.